Purified ILCs from non-affected colon, tumor border and central tumor tissue were cultured in the presence of IL-2 plus IL-1β and IL-18 for 7−9 days and the resulting expression of HLA-DR and T-cell co-stimulatory molecules was assessed (Fig. 7). The gene discussed is IL1B; the disease is neoplasm.